17 August 2021 - As the Government has gradually increased reimbursement for combination drugs treating chronic lymphocytic leukaemia, patients’ hopes are growing for more diverse treatment options.
Recently, access to its treatment options using oral drugs alone or in combination with others has been enhanced in Korea, considering the characteristics of the disease with a high proportion of elderly patients.